title: Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens.
abstract: A rarely challenged dogma in cell-mediated immune (CMI) assays is the incubation temperature, 37°C. Fever augments proinflammatory immune responses in vivo, and the aim of this study was to explore whether incubation at fever-range temperature could increase antigen-specific biomarker responses. We compared CMI responses following incubation of whole blood at 37°C and 39°C. Whole blood was obtained from (i) 34 healthy subjects whose blood was incubated with TB10.4 antigen, present in the Mycobacterium bovis bacillus Calmette-Guérin vaccine and many environmental mycobacteria; (ii) 8 TB patients and 8 controls incubated with Mycobacterium tuberculosis-specific antigens in the QuantiFERON-TB Gold test (QFT-IT); and (iii) from both groups incubated with a T cell mitogen. T cell responses (gamma interferon [IFN-γ]) and responses from antigen-presenting cells (IFN-γ-induced protein 10 [IP-10]) were determined. We further evaluated the effect of adding interleukin-7 (IL-7) and blocking IL-10 during incubation. In TB patients, IFN-γ and IP-10 levels were increased 4.1- and 3.4-fold, respectively, at 39°C incubation (P < 0.001). Similar results were seen after mitogen stimulation. In subjects responding to TB10.4, the effects were less pronounced and significant only for IP-10. Incubation at 39°C increased IP-10 and IFN-γ responsiveness to both antigens and mitogen in persons with baseline or initial low responses. Adding IL-7 and blocking IL-10 augmented the effects in synergy with fever-range temperature. Incubation at fever-range temperature vividly increases CMI responsiveness to antigen stimulation in vitro in tuberculosis patients and may increase the sensitivity of CMI assays.
authors: Clinical Research Centre, University of Copenhagen, Hvidovre Hospital, Copenhagen 2650, Denmark.
authors: Martine G
authors: MG
authors: Aabye
authors: Pernille
authors: P
authors: Ravn
authors: Isik S
authors: IS
authors: Johansen
authors: Jesper
authors: J
authors: Eugen-Olsen
authors: Morten
authors: M
authors: Ruhwald
references: Eur Respir J. 2008 Dec;32(6):1607-15
references: 18684849
references: Immunology. 2010 Jul;130(3):418-26
references: 20465565
references: J Leukoc Biol. 2003 Apr;73(4):493-501
references: 12660224
references: Microbes Infect. 2007 Jun;9(7):806-12
references: 17533146
references: Clin Vaccine Immunol. 2007 Nov;14(11):1483-9
references: 17881504
references: Int Immunol. 2003 Sep;15(9):1053-61
references: 12917257
references: Infect Immun. 1977 Dec;18(3):673-9
references: 412788
references: Expert Rev Respir Med. 2009 Aug;3(4):387-401
references: 20477330
references: AIDS. 2010 Jan 16;24(2):323-5
references: 20010069
references: Clin Vaccine Immunol. 2009 Aug;16(8):1196-202
references: 19571108
references: Int J Tuberc Lung Dis. 2009 Jun;13(6):731-6
references: 19460249
references: BMC Res Notes. 2009 Jan 15;2:9
references: 19146687
references: PLoS One. 2010 Feb 04;5(2):e9051
references: 20140219
references: Cancer Immunol Immunother. 2006 Mar;55(3):292-8
references: 15864585
references: Clin Vaccine Immunol. 2010 Apr;17(4):596-601
references: 20181768
references: Intensive Care Med. 2000 Nov;26(11):1646-51
references: 11193271
references: BMC Res Notes. 2009 Feb 04;2:19
references: 19193208
references: Int J Tuberc Lung Dis. 2010 Mar;14(3):347-55
references: 20132627
references: Eur Respir J. 2011 Jan;37(1):100-11
references: 20847080
references: J Infect. 2010 Feb;60(2):133-9
references: 19878691
references: Jpn J Surg. 1990 Jan;20(1):119-22
references: 2304283
references: Cytokine Growth Factor Rev. 2010 Oct;21(5):331-44
references: 21115385
references: Immunity. 2010 Oct 29;33(4):451-63
references: 21029957
references: Am J Respir Crit Care Med. 2004 Jul 1;170(1):59-64
references: 15059788
references: Cancer Lett. 2008 Nov 28;271(2):191-204
references: 18597930
references: Clin Vaccine Immunol. 2008 Oct;15(10):1616-22
references: 18753334
references: Nat Rev Microbiol. 2005 Aug;3(8):656-62
references: 16012514
references: J Immunol Methods. 2002 Dec 1;270(1):99-108
references: 12379342
references: J Immunol. 2007 Jun 15;178(12):7730-7
references: 17548610
references: Eur Respir J. 2010 Dec;36(6):1488-90
references: 21119209
references: Infect Immun. 2002 Oct;70(10):5446-53
references: 12228269
references: Tuberculosis (Edinb). 2010 Nov;90(6):346-53
references: 20933471
references: Lancet. 2000 Sep 23;356(9235):1099-104
references: 11009160
references: Tuberculosis (Edinb). 2007 Nov;87(6):465-73
references: 17719276
references: Cancer Immunol Immunother. 2006 Dec;55(12):1459-69
references: 16491400
references: Exp Mol Pathol. 1991 Oct;55(2):119-34
references: 1657630